세계의 미생물 리파아제 시장 예측(-2030년) : 공급원, 형태, 순도, 기능성, 최종 사용자 및 지역별 분석

According to Stratistics MRC, the Global Microbial Lipase Market is accounted for $657.27 million in 2023 and is expected to reach $1170.98 million by 2030 growing at a CAGR of 8.6% during the forecast period. Microbial lipase, an enzyme produced by microorganisms like bacteria and fungi, plays a pivotal role in lipid metabolism. It catalyzes the hydrolysis of ester bonds in triglycerides, breaking them down into glycerol and fatty acids. It enhances flavour and texture, and facilitates fat digestion. Its stability across a broad pH and temperature range makes it valuable in industrial processes.

Market Dynamics:

Driver:

Increased awareness about enzyme-based solutions

Enzyme-based solutions, particularly microbial lipases, offer sustainable and eco-friendly alternatives for processes like food production, biofuel manufacturing, and pharmaceuticals. As industries seek more efficient and environmentally friendly solutions, the demand for microbial lipases increases. Their ability to catalyze specific reactions with high specificity and efficiency, coupled with advancements in enzyme engineering and production technologies, further solidifies their position as essential biocatalysts, driving market expansion.

Restraint:

Limited stability and shelf-life

Limited stability and shelf-life in microbial lipases stem from factors such as enzyme denaturation, proteolysis, and aggregation, which can occur during storage or under unfavourable conditions. These limitations hinder their efficacy and suitability for various industrial applications, affecting product quality and performance. Consequently, industries may seek alternative enzyme sources or synthetic substitutes with longer shelf-life and greater stability, reducing reliance on microbial lipases.

Opportunity:

Expanding biotechnology sector

Microbial lipases play crucial roles in biotechnology applications such as biofuel production, pharmaceutical synthesis, and detergent manufacturing. As biotechnology continues to advance, the demand for microbial lipases is expected to rise further, driven by their versatility, efficiency, and eco-friendly nature. This trend fosters innovation in microbial lipase development, enhancing their performance and widening their application scope, thereby fueling market expansion within the biotechnology sector.

Threat:

Technical challenges

Technical challenges in microbial lipase include formulation optimization, process condition fine-tuning, and substrate compatibility. Ensuring optimal enzyme stability and activity across varied industrial conditions poses difficulties. Moreover, achieving cost-effective production methods without compromising quality remains a challenge. These technical hurdles hinder widespread adoption and application of microbial lipases, impacting market growth.

Covid-19 Impact

The covid-19 pandemic has had a mixed impact on the microbial lipase market. While the increased demand for processed foods and detergents has driven up the need for microbial lipases in certain sectors, disruptions in the supply chain, workforce shortages, and economic uncertainties have posed challenges for market players. Additionally, the temporary closure of industries and reduced consumer spending has dampened market growth. However, the market has shown resilience, with rapid adaptation to remote work, increased focus on hygiene products, and accelerated research in biotechnology driving recovery and future growth prospects.

The bacteria segment is expected to be the largest during the forecast period

The bacteria segment is estimated to have a lucrative growth. Microbial lipases, enzymes produced by bacteria, play vital roles in various industrial applications. Derived from diverse bacterial strains, these lipases exhibit remarkable substrate specificity and stability under different conditions, making them invaluable in biotechnology, food processing, and pharmaceuticals. They catalyze the hydrolysis of ester bonds in lipids, facilitating processes like cheese ripening, detergent formulation, and biodiesel production.

The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical companies segment is anticipated to witness the highest CAGR growth during the forecast period. Microbial lipase, an enzyme produced by microorganisms like bacteria and fungi, finds crucial applications in pharmaceutical companies. Its role in drug formulation involves aiding in the synthesis of pharmaceutical compounds, enhancing drug absorption, and improving drug stability. They are essential for the production of enantiomerically pure drugs, thereby ensuring efficacy and minimizing side effects.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period. Rapid industrialization, expanding food and beverage sectors, and increasing demand for enzyme-based products are fueling market expansion. Additionally, rising disposable incomes and changing dietary preferences towards healthier and convenience foods are boosting the demand for microbial lipases in the region. Moreover, favourable government initiatives supporting biotechnology research and development are further propelling market growth.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period. The region's advanced food and beverage industry, coupled with a growing demand for enzyme-based solutions, is a primary driver. Furthermore, technological advancements, robust research and development activities, and a supportive regulatory framework are contributing to market expansion. With a focus on sustainability and innovation, the North American microbial lipase market is expected to continue its upward trajectory in the coming years.

Key players in the market

Some of the key players profiled in the Microbial Lipase Market include Novozymes A/S, DuPont de Nemours, Inc., DSM Nutritional Products, AB Enzymes GmbH, Amano Enzyme Inc., Chr. Hansen Holding A/S, BASF SE, Associated British Foods PLC, Enzyme Development Corporation, Biocatalysts Limited, BioResource International Inc., Novus International Inc., Enzyme Solutions Limited, Koninklijke DSM N.V., Kerry Group and Sunson Industry Group.

Key Developments:

In October 2023, BASF strengthens its enzyme technology for detergents and cleaners with the launch of a new enzymes' generation from its Lavergy(R) portfolio. With the latest expansion of its enzyme portfolio, BASF is raising the bar as an innovation leader and provider of key ingredients for the home care and I&I industry.

In May 2020, Biocatalysts Ltd launched new enzyme Lipomod(R) 767P, it is non-genetically modified microbial lipase preparation suitable for both the hydrolysis and esterification of oils and fats. Its broad spectrum pH profile means it can be used in applications across a wide range of substrate types. This product is an addition to Biocatalyst's extensive range of microbial enzymes, which have been developed to meet the growing demand for clean label products.

Sources Covered:

• Bacteria
• Fungi
• Yeast
• Other Sources

Forms Covered:

• Liquid
• Powder
• Granular
• Other Forms

Purities Covered:

• Pure Lipase
• Technical Grade Lipase
• Crude Lipase
• Other Purities

Functionalities Covered:

• Lipolysis
• Transesterification
• Interesterification
• Esterification
• Other Functionalities

End Users Covered:

• Food Processing Companies
• Pharmaceutical Companies
• Cosmetic Companies
• Biofuel Manufacturers
• Textile Manufacturers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Microbial Lipase Market, By Source

• 5.1 Introduction
• 5.2 Bacteria
• 5.3 Fungi
• 5.4 Yeast
• 5.5 Other Sources

6 Global Microbial Lipase Market, By Form

• 6.1 Introduction
• 6.2 Liquid
• 6.3 Powder
• 6.4 Granular
• 6.5 Other Forms

7 Global Microbial Lipase Market, By Purity

• 7.1 Introduction
• 7.2 Pure Lipase
• 7.3 Technical Grade Lipase
• 7.4 Crude Lipase
• 7.5 Other Purities

8 Global Microbial Lipase Market, By Functionality

• 8.1 Introduction
• 8.2 Lipolysis
• 8.3 Transesterification
• 8.4 Interesterification
• 8.5 Esterification
• 8.6 Other Functionalities

9 Global Microbial Lipase Market, By End User

• 9.1 Introduction
• 9.2 Food Processing Companies
• 9.3 Pharmaceutical Companies
• 9.4 Cosmetic Companies
• 9.5 Biofuel Manufacturers
• 9.6 Textile Manufacturers
• 9.7 Other End Users

10 Global Microbial Lipase Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Novozymes A/S
• 12.2 DuPont de Nemours, Inc.
• 12.3 DSM Nutritional Products
• 12.4 AB Enzymes GmbH
• 12.5 Amano Enzyme Inc.
• 12.6 Chr. Hansen Holding A/S
• 12.7 BASF SE
• 12.8 Associated British Foods PLC
• 12.9 Enzyme Development Corporation
• 12.10 Biocatalysts Limited
• 12.11 BioResource International Inc.
• 12.12 Novus International Inc.
• 12.13 Enzyme Solutions Limited
• 12.14 Koninklijke DSM N.V.
• 12.15 Kerry Group
• 12.16 Sunson Industry Group